Dapagliflozin meets endpoint in top-line DECLARE results, AstraZeneca says September 25, 2018Diabetes
GBS in T2DM patients: Study highlights pros and cons, need for better patient selectionSeptember 21, 2018Diabetes
Review protocols, follow reprocessing guidelines to cut device-related HAIsSeptember 11, 2018Diabetes
